Arrowhead Pharmaceuticals Aktie
14,04
EUR
+0,19
EUR
+1,34
%
15,33
USD
+0,30
USD
+2,00
%
Werbung
Arrowhead Pharmaceuticals Aktie Analyse
12.02.18 | Arrowhead Pharmaceuticals Neutral | Cantor Fitzgerald | |
12.02.18 | Arrowhead Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
05.01.18 | Arrowhead Pharmaceuticals Neutral | B. Riley FBR, Inc. | |
30.11.16 | Arrowhead Pharmaceuticals Mkt Perform | William Blair | |
30.11.16 | Arrowhead Pharmaceuticals Hold | Cantor Fitzgerald | |
30.11.16 | Arrowhead Pharmaceuticals Neutral | Chardan Capital Markets | |
09.10.14 | Arrowhead Pharmaceuticals Sector Perform | RBC Capital Markets |
Werbung
Werbung